1. Home
  2. AMRX vs HAFN Comparison

AMRX vs HAFN Comparison

Compare AMRX & HAFN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Amneal Pharmaceuticals Inc.

AMRX

Amneal Pharmaceuticals Inc.

HOLD

Current Price

$11.92

Market Cap

3.7B

Sector

Health Care

ML Signal

HOLD

Logo Hafnia Limited

HAFN

Hafnia Limited

HOLD

Current Price

$8.73

Market Cap

4.4B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
AMRX
HAFN
Founded
2002
2012
Country
United States
Singapore
Employees
N/A
4876
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.7B
4.4B
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
AMRX
HAFN
Price
$11.92
$8.73
Analyst Decision
Strong Buy
Analyst Count
5
0
Target Price
$15.60
N/A
AVG Volume (30 Days)
1.5M
1.5M
Earning Date
05-01-2026
05-14-2026
Dividend Yield
N/A
6.21%
EPS Growth
157.89
N/A
EPS
0.19
N/A
Revenue
N/A
N/A
Revenue This Year
$4.48
N/A
Revenue Next Year
$7.13
N/A
P/E Ratio
$64.32
$11.39
Revenue Growth
N/A
N/A
52 Week Low
$7.02
$4.90
52 Week High
$15.42
$9.54

Technical Indicators

Market Signals
Indicator
AMRX
HAFN
Relative Strength Index (RSI) 35.55 54.79
Support Level $11.60 $7.95
Resistance Level $12.12 $9.54
Average True Range (ATR) 0.40 0.25
MACD -0.13 -0.07
Stochastic Oscillator 2.04 23.22

Price Performance

Historical Comparison
AMRX
HAFN

About AMRX Amneal Pharmaceuticals Inc.

Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE. It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment, which derives maximum revenue, focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.

About HAFN Hafnia Limited

Hafnia Ltd is one of the tanker owners, transporting oil, oil products and chemicals for national and international oil companies, chemical companies, as well as trading and utility companies. As owners and operators of around 200 vessels, It offers a fully integrated shipping platform, including technical management, commercial and chartering services, pool management, and a large-scale bunker procurement desk. Company manages it's business through the following reporting segments: LR2 tankers, LR1 tankers, MR tankers, Handy tankers.

Share on Social Networks: